Blacklisting of MD Life Sciences Ltd
The National Agency for Food and Drug Administration and Control (NAFDAC) has officially blacklisted MD Life Sciences Ltd, situated at Water Rock Greens, 21 Old Airport Road, Emene Industrial Layout, Enugu State. This sanction arises from serious regulatory breaches: engaging unauthorized third-party manufacturers without NAFDAC approval and distributing products without stated active ingredients. MD Life […]
Blacklisting of Ocean Plus Pharma Ltd
In accordance with its mandate to safeguard public health, NAFDAC hereby issues a formal notice of blacklisting of OCEAN PLUS PHARM LTD, no 1, Isieke Street, Asaba, Delta State. Following routine post-marketing surveillance, samples of a batch of unregistered CHRICLAV (Amoxicillin/ Clavulanic acid) dry powder for oral suspension manufactured by CHRICURE PHARM, 174 – B, […]
Blacklisting of Acme Healthcare Limited
The National Agency for Food and Drug Administration and Control (NAFDAC) has officially blacklisted ACME Healthcare Limited, located at No. 3 Church Street, Lakowe Phase 2, Lekki Expressway, Lagos, as well as anywhere else the company operates. This action is a result of serious regulatory violations, including the unauthorized importation and distribution of several products: […]
Blacklisting of MedVue Pharmaceutical Ltd
In accordance with its mandate to safeguard public health, NAFDAC hereby issues a formal notice of blacklisting of MedVue Pharmaceutical Ltd. Following routine post-marketing surveillance, samples of the above batch of Amoxivue (Amoxicillin) 500mg marketed by MedVue Pharmaceutical Ltd were collected from facilities in Sokoto and Plateau State. Laboratory analysis using High-Performance Liquid Chromatography (HPLC) […]
Blacklisting of NITIN Lifesciences Ltd
The National Agency for Food and Drug Administration and Control (NAFDAC) hereby issue this Public Notice to inform the general public, healthcare institutions, pharmaceutical importers, distributors, and all relevant stakeholders of the blacklisting of NITIN Lifesciences Ltd, an India‑based pharmaceutical manufacturer. NAFDAC investigations confirmed that ACME Healthcare Limited imported and distributed pharmaceutical products manufactured by […]
Blacklisting of ANHUI HONGYE Pharmaceutical Co. Ltd
The National Agency for Food and Drug Administration and Control (NAFDAC) hereby issues this public notice to inform all stakeholders, importers, distributors, healthcare practitioners, and the general public of the blacklisting of Anhui Hongye Pharmaceutical Co., Ltd, located at Fengyang East Road 76, Bengbu, Anhui Province, China. Following a regulatory investigation, NAFDAC has confirmed that […]
Public Alert No. 020/2026 -Alert on Unregistered ViroActive+ Drug Purported to Cure HIV
The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting healthcare providers, patients, and the public about a report concerning the circulation of unregistered ViroActive+ Capsules in Nigeria. This report was received as a complaint in the Bauchi state NAFDAC office. The unregistered ViroActive+ is a drug purported to cure HIV. It […]
Public Alert No.019/2026 – Alert on Mop up of all Otrivin Nasal Drops (0.05% and 0.1%)
The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting healthcare providers and the public about a report concerning the circulation of counterfeit and unregistered Otrivin Nasal drops (0.05%) for children and (0.01%) for adults in Nigeria. The Post Marketing Surveillance (PMS) Directorate of the Agency received a consumer complaint of an […]
Public Alert No. 018/2026 – Alert on Counterfeit and Unregistered Cerelac Found on Sale
The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting healthcare providers, caregivers, and the public about reports of suspected counterfeit and unregistered CERELAC Mixed Fruits and Wheat products being sold in Lagos State, Nigeria. Nestle Nigeria Plc, the genuine Marketing Authorization Holder for CERELAC Mixed Fruits and Wheat, received a complaint […]
Public Alert No. 017/2026 – Alert on Confirmed Counterfeit of Herceptin 600 mg in Nigeria
The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying healthcare professionals and the public of a confirmed counterfeit batch of Herceptin 600 mg circulating in Nigeria. This alert follows official communications from Roche Nigeria confirming a counterfeit case of Herceptin 600 mg with batch number A8519B34 reported in Lagos state, Nigeria. […]
